Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Improving Practice Patterns for the Treatment of Hypertension

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00265044
First received: December 12, 2005
Last updated: April 16, 2014
Last verified: April 2014
  Purpose

To improve the quality of hypertension care in our facility, while concurrently, examining the relative contribution of each aspect of a multi-factorial intervention designed to improve hypertension care.


Condition Intervention
Hypertension
Behavioral: Provider Education
Behavioral: Hypertension Alert
Behavioral: Patient Education

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Innovations to Implementing Evidence-based Clinical Practice

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Reaching Systolic BP goal 6 months after intervention [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Reaching Diastolic BP goal 6 months after intervention Any additional prescriptions of antihypertensive medications. [ Designated as safety issue: No ]

Estimated Enrollment: 1300
Study Start Date: January 2004
Study Completion Date: December 2004
Arms Assigned Interventions
Arm 1 Behavioral: Provider Education Behavioral: Hypertension Alert Behavioral: Patient Education

Detailed Description:

This project was a randomized trial designed to examine the relative contribution of three quality improvement interventions of increasing intensity on BP control in veterans. Providers in each stratum and their eligible patients were randomized to one of three study arms. The providers randomized to the first arm received education alone, and were considered the controls. Providers randomized to the second arm received both provider education and a hypertension alert. The third arm included provider education, a hypertension alert, and patient education. Patients were eligible for inclusion if they were aged 21- 90 years and filled their medications with the VA pharmacies. Between July and December 2003, we determined patient eligibility using a search strategy using data from the Mid South Quality Improvement Data warehouse, which is downloaded monthly from Veterans' Health Information System and Technology Architecture (VistA).

  Eligibility

Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Patients were eligible for inclusion if they were aged 21- 90 years and filled their medications with the VA pharmacies. Seen in 2003 and had a primary care visit coded as hypertension using International Classification of Diseases Ninth Revision; Clinical Modification (ICD 9-CM) (24) of 401.1 or 401.9 and who were prescribed only one antihypertensive medication

Exclusion Criteria:

More than one antihypertensive medication Refuse consent to review medical record Pregnant Prisoners

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00265044

Locations
United States, Tennessee
VA Medical Center, Nashville
Nashville, Tennessee, United States, 37212-2637
Sponsors and Collaborators
Investigators
Principal Investigator: Theodore Speroff, PhD Department of Veterans Affairs
Principal Investigator: Christianne L Roumie, BA MD MPH VA Medical Center, Nashville
Principal Investigator: Vincent Alvarez VA Medical Center, Nashville
  More Information

Publications:
Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00265044     History of Changes
Other Study ID Numbers: IMV 04-091
Study First Received: December 12, 2005
Last Updated: April 16, 2014
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Behavior Change
patient Education

Additional relevant MeSH terms:
Hypertension
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on November 25, 2014